173 related articles for article (PubMed ID: 37080989)
1. Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma.
Hao J; Han X; Huang H; Yu X; Fang J; Zhao J; Prayson RA; Bao S; Yu JS
Nat Commun; 2023 Apr; 14(1):2262. PubMed ID: 37080989
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of Tumor Suppressive Function of FBXO16 Ubiquitin Ligase Activates Wnt Signaling In Glioblastoma.
Khan M; Muzumdar D; Shiras A
Neoplasia; 2019 Jan; 21(1):106-116. PubMed ID: 30530053
[TBL] [Abstract][Full Text] [Related]
3. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
[TBL] [Abstract][Full Text] [Related]
4. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
[TBL] [Abstract][Full Text] [Related]
5. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
[TBL] [Abstract][Full Text] [Related]
6. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition.
Kahlert UD; Maciaczyk D; Doostkam S; Orr BA; Simons B; Bogiel T; Reithmeier T; Prinz M; Schubert J; Niedermann G; Brabletz T; Eberhart CG; Nikkhah G; Maciaczyk J
Cancer Lett; 2012 Dec; 325(1):42-53. PubMed ID: 22652173
[TBL] [Abstract][Full Text] [Related]
7. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
[TBL] [Abstract][Full Text] [Related]
8. Wnt pathway markers in molecular subgroups of glioblastoma.
Tompa M; Nagy A; Komoly S; Kalman B
Brain Res; 2019 Sep; 1718():114-125. PubMed ID: 31075260
[TBL] [Abstract][Full Text] [Related]
9. Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.
Han M; Wang S; Fritah S; Wang X; Zhou W; Yang N; Ni S; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
Brain; 2020 Feb; 143(2):512-530. PubMed ID: 31891366
[TBL] [Abstract][Full Text] [Related]
10. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway.
Wang Y; Gao G; Wei X; Zhang Y; Yu J
Drug Des Devel Ther; 2023; 17():1357-1369. PubMed ID: 37181827
[TBL] [Abstract][Full Text] [Related]
11. Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study.
Jamalpour S; Alinezhad A; Sabah JT; Vazifehmand R; Behrooz AB; Hamzah ASA; Davazdahemami AA; Homaie FM; Maddah SM
Chem Pharm Bull (Tokyo); 2023; 71(10):766-774. PubMed ID: 37779078
[TBL] [Abstract][Full Text] [Related]
12. Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation.
Man J; Shoemake J; Zhou W; Fang X; Wu Q; Rizzo A; Prayson R; Bao S; Rich JN; Yu JS
Cell Rep; 2014 Dec; 9(5):1812-1826. PubMed ID: 25464848
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.
Tompa M; Kalovits F; Nagy A; Kalman B
Neuromolecular Med; 2018 Dec; 20(4):437-451. PubMed ID: 30259273
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
Tomar VS; Patil V; Somasundaram K
Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
[TBL] [Abstract][Full Text] [Related]
15. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
16. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
[TBL] [Abstract][Full Text] [Related]
17. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
Li C; Yang J; Lei S; Wang W
Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
[TBL] [Abstract][Full Text] [Related]
18. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
[TBL] [Abstract][Full Text] [Related]
20. Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas.
Pulvirenti T; Van Der Heijden M; Droms LA; Huse JT; Tabar V; Hall A
Cancer Res; 2011 Dec; 71(23):7280-90. PubMed ID: 21990322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
